Loading…

Anatoxin-a is a potent agonist of the nicotinic acetylcholine receptor of bovine adrenal chromaffin cells

(+)-Anatoxin-a is a neurotoxic alkaloid produced by the cyanobacterium Anabaena flos-aquae. In this study synthetic (±)-anatoxin-a was tested on isolated bovine adrenal chromaffin cells to determine its ability to evoke secretion of endogenous catecholamines through neuronal-type nicotinic receptor...

Full description

Saved in:
Bibliographic Details
Published in:European journal of pharmacology 1995-05, Vol.289 (3), p.447-453
Main Authors: Molloy, Leah, Wonnacott, Susan, Gallagher, Timothy, Brough, Paul A., Livett, Bruce G.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c417t-d6e38498e88ddf2f771e99fc4f2590e0000f34419e216db23383ba694459d6823
cites cdi_FETCH-LOGICAL-c417t-d6e38498e88ddf2f771e99fc4f2590e0000f34419e216db23383ba694459d6823
container_end_page 453
container_issue 3
container_start_page 447
container_title European journal of pharmacology
container_volume 289
creator Molloy, Leah
Wonnacott, Susan
Gallagher, Timothy
Brough, Paul A.
Livett, Bruce G.
description (+)-Anatoxin-a is a neurotoxic alkaloid produced by the cyanobacterium Anabaena flos-aquae. In this study synthetic (±)-anatoxin-a was tested on isolated bovine adrenal chromaffin cells to determine its ability to evoke secretion of endogenous catecholamines through neuronal-type nicotinic receptor activation. Anatoxin-a was found to act as a potent agonist of the secretory response of chromaffin cells with an EC 50 of 1–2 μM, compared with an EC 50 of 4–5 μM for nicotine. The cells responded to anatoxin-a and nicotine with bell-shaped concentration-response curves consistent with desensitisation at concentrations of anatoxin-a greater than 5 μM and of nicotine greater than 20 μM. The secretion of catecholamines stimulated by anatoxin-a was completely inhibited in a non-competitive manner by the nicotinic antagonist mecamylamine with an IC 50 of 0.4–0.5 μM. In the presence of depolarising concentrations of K + (15 or 50 mM), anatoxin-a increased the secretion of catecholamines in a concentration-dependent manner up to the same maximum as that achieved by anatoxin-a alone. It is concluded that anatoxin-a acts as a potent and selective nicotinic agonist, capable of evoking secretion of endogenous catecholamines from chromaffin cells via their neuronal-type nicotinic receptor.
doi_str_mv 10.1016/0922-4106(95)90153-1
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_15597816</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0922410695901531</els_id><sourcerecordid>15597816</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-d6e38498e88ddf2f771e99fc4f2590e0000f34419e216db23383ba694459d6823</originalsourceid><addsrcrecordid>eNp9kEtPAyEQgDlotD7-gSYcjNHDKiywu1xMTOMrMfGiZ0JhsJgtVKBG_727tunRy0wy880wfAidUHJFCW2uiazrilPSXEhxKQkVrKI7aLIt76ODnD8IIZJKvof2WiEaTtkE-dugS_z2odLYZ6zxMhYIBev3GHwuODpc5oCDN7H4IWJtoPz0Zh57HwAnMLAsMY3cLH6NJW0TBN1jM09xoZ3zARvo-3yEdp3uMxxv8iF6u797nT5Wzy8PT9Pb58pw2pbKNsA6LjvoOmtd7dqWgpTOcFcLSWD4AnGMcyqhpo2d1Yx1bKYbybmQtulqdojO13uXKX6uIBe18Hm8QAeIq6yoELLtaDOAfA2aFHNO4NQy-YVOP4oSNVpVoz416lNSqD-rig5jp5v9q9kC7HZoo3Ton236Ohvdu6SD8XmLsfF5QQbsZo3B4OLLQ1LZeAgGrB-kFmWj__-OX6aylVY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15597816</pqid></control><display><type>article</type><title>Anatoxin-a is a potent agonist of the nicotinic acetylcholine receptor of bovine adrenal chromaffin cells</title><source>ScienceDirect Freedom Collection</source><creator>Molloy, Leah ; Wonnacott, Susan ; Gallagher, Timothy ; Brough, Paul A. ; Livett, Bruce G.</creator><creatorcontrib>Molloy, Leah ; Wonnacott, Susan ; Gallagher, Timothy ; Brough, Paul A. ; Livett, Bruce G.</creatorcontrib><description>(+)-Anatoxin-a is a neurotoxic alkaloid produced by the cyanobacterium Anabaena flos-aquae. In this study synthetic (±)-anatoxin-a was tested on isolated bovine adrenal chromaffin cells to determine its ability to evoke secretion of endogenous catecholamines through neuronal-type nicotinic receptor activation. Anatoxin-a was found to act as a potent agonist of the secretory response of chromaffin cells with an EC 50 of 1–2 μM, compared with an EC 50 of 4–5 μM for nicotine. The cells responded to anatoxin-a and nicotine with bell-shaped concentration-response curves consistent with desensitisation at concentrations of anatoxin-a greater than 5 μM and of nicotine greater than 20 μM. The secretion of catecholamines stimulated by anatoxin-a was completely inhibited in a non-competitive manner by the nicotinic antagonist mecamylamine with an IC 50 of 0.4–0.5 μM. In the presence of depolarising concentrations of K + (15 or 50 mM), anatoxin-a increased the secretion of catecholamines in a concentration-dependent manner up to the same maximum as that achieved by anatoxin-a alone. It is concluded that anatoxin-a acts as a potent and selective nicotinic agonist, capable of evoking secretion of endogenous catecholamines from chromaffin cells via their neuronal-type nicotinic receptor.</description><identifier>ISSN: 0922-4106</identifier><identifier>ISSN: 0014-2999</identifier><identifier>DOI: 10.1016/0922-4106(95)90153-1</identifier><identifier>PMID: 7556413</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Adrenaline release ; Anabaena flos-aquae ; Anatoxin-a ; Animals ; Bacterial Toxins - antagonists &amp; inhibitors ; Bacterial Toxins - pharmacology ; Biological and medical sciences ; Cattle ; Cells, Cultured ; Cholinergic system ; Chromaffin cell ; Chromaffin System - cytology ; Chromaffin System - drug effects ; Chromaffin System - metabolism ; Cyanophyta ; Epinephrine - metabolism ; Marine Toxins - antagonists &amp; inhibitors ; Marine Toxins - pharmacology ; Mecamylamine ; Mecamylamine - pharmacology ; Medical sciences ; Microcystins ; Neuropharmacology ; Neurotoxins - antagonists &amp; inhibitors ; Neurotoxins - pharmacology ; Neurotransmitters. Neurotransmission. Receptors ; Nicotine - pharmacology ; Nicotinic acetylcholine receptor, neuronal type ; Nicotinic Agonists - pharmacology ; Nicotinic receptor agonist ; Noradrenaline release ; Norepinephrine - metabolism ; Pharmacology. Drug treatments ; Potassium - pharmacology ; Tropanes</subject><ispartof>European journal of pharmacology, 1995-05, Vol.289 (3), p.447-453</ispartof><rights>1995</rights><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-d6e38498e88ddf2f771e99fc4f2590e0000f34419e216db23383ba694459d6823</citedby><cites>FETCH-LOGICAL-c417t-d6e38498e88ddf2f771e99fc4f2590e0000f34419e216db23383ba694459d6823</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3559750$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7556413$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Molloy, Leah</creatorcontrib><creatorcontrib>Wonnacott, Susan</creatorcontrib><creatorcontrib>Gallagher, Timothy</creatorcontrib><creatorcontrib>Brough, Paul A.</creatorcontrib><creatorcontrib>Livett, Bruce G.</creatorcontrib><title>Anatoxin-a is a potent agonist of the nicotinic acetylcholine receptor of bovine adrenal chromaffin cells</title><title>European journal of pharmacology</title><addtitle>Eur J Pharmacol</addtitle><description>(+)-Anatoxin-a is a neurotoxic alkaloid produced by the cyanobacterium Anabaena flos-aquae. In this study synthetic (±)-anatoxin-a was tested on isolated bovine adrenal chromaffin cells to determine its ability to evoke secretion of endogenous catecholamines through neuronal-type nicotinic receptor activation. Anatoxin-a was found to act as a potent agonist of the secretory response of chromaffin cells with an EC 50 of 1–2 μM, compared with an EC 50 of 4–5 μM for nicotine. The cells responded to anatoxin-a and nicotine with bell-shaped concentration-response curves consistent with desensitisation at concentrations of anatoxin-a greater than 5 μM and of nicotine greater than 20 μM. The secretion of catecholamines stimulated by anatoxin-a was completely inhibited in a non-competitive manner by the nicotinic antagonist mecamylamine with an IC 50 of 0.4–0.5 μM. In the presence of depolarising concentrations of K + (15 or 50 mM), anatoxin-a increased the secretion of catecholamines in a concentration-dependent manner up to the same maximum as that achieved by anatoxin-a alone. It is concluded that anatoxin-a acts as a potent and selective nicotinic agonist, capable of evoking secretion of endogenous catecholamines from chromaffin cells via their neuronal-type nicotinic receptor.</description><subject>Adrenaline release</subject><subject>Anabaena flos-aquae</subject><subject>Anatoxin-a</subject><subject>Animals</subject><subject>Bacterial Toxins - antagonists &amp; inhibitors</subject><subject>Bacterial Toxins - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Cattle</subject><subject>Cells, Cultured</subject><subject>Cholinergic system</subject><subject>Chromaffin cell</subject><subject>Chromaffin System - cytology</subject><subject>Chromaffin System - drug effects</subject><subject>Chromaffin System - metabolism</subject><subject>Cyanophyta</subject><subject>Epinephrine - metabolism</subject><subject>Marine Toxins - antagonists &amp; inhibitors</subject><subject>Marine Toxins - pharmacology</subject><subject>Mecamylamine</subject><subject>Mecamylamine - pharmacology</subject><subject>Medical sciences</subject><subject>Microcystins</subject><subject>Neuropharmacology</subject><subject>Neurotoxins - antagonists &amp; inhibitors</subject><subject>Neurotoxins - pharmacology</subject><subject>Neurotransmitters. Neurotransmission. Receptors</subject><subject>Nicotine - pharmacology</subject><subject>Nicotinic acetylcholine receptor, neuronal type</subject><subject>Nicotinic Agonists - pharmacology</subject><subject>Nicotinic receptor agonist</subject><subject>Noradrenaline release</subject><subject>Norepinephrine - metabolism</subject><subject>Pharmacology. Drug treatments</subject><subject>Potassium - pharmacology</subject><subject>Tropanes</subject><issn>0922-4106</issn><issn>0014-2999</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><recordid>eNp9kEtPAyEQgDlotD7-gSYcjNHDKiywu1xMTOMrMfGiZ0JhsJgtVKBG_727tunRy0wy880wfAidUHJFCW2uiazrilPSXEhxKQkVrKI7aLIt76ODnD8IIZJKvof2WiEaTtkE-dugS_z2odLYZ6zxMhYIBev3GHwuODpc5oCDN7H4IWJtoPz0Zh57HwAnMLAsMY3cLH6NJW0TBN1jM09xoZ3zARvo-3yEdp3uMxxv8iF6u797nT5Wzy8PT9Pb58pw2pbKNsA6LjvoOmtd7dqWgpTOcFcLSWD4AnGMcyqhpo2d1Yx1bKYbybmQtulqdojO13uXKX6uIBe18Hm8QAeIq6yoELLtaDOAfA2aFHNO4NQy-YVOP4oSNVpVoz416lNSqD-rig5jp5v9q9kC7HZoo3Ton236Ohvdu6SD8XmLsfF5QQbsZo3B4OLLQ1LZeAgGrB-kFmWj__-OX6aylVY</recordid><startdate>19950526</startdate><enddate>19950526</enddate><creator>Molloy, Leah</creator><creator>Wonnacott, Susan</creator><creator>Gallagher, Timothy</creator><creator>Brough, Paul A.</creator><creator>Livett, Bruce G.</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>F1W</scope><scope>FR3</scope><scope>H99</scope><scope>L.F</scope><scope>L.G</scope><scope>P64</scope></search><sort><creationdate>19950526</creationdate><title>Anatoxin-a is a potent agonist of the nicotinic acetylcholine receptor of bovine adrenal chromaffin cells</title><author>Molloy, Leah ; Wonnacott, Susan ; Gallagher, Timothy ; Brough, Paul A. ; Livett, Bruce G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-d6e38498e88ddf2f771e99fc4f2590e0000f34419e216db23383ba694459d6823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Adrenaline release</topic><topic>Anabaena flos-aquae</topic><topic>Anatoxin-a</topic><topic>Animals</topic><topic>Bacterial Toxins - antagonists &amp; inhibitors</topic><topic>Bacterial Toxins - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Cattle</topic><topic>Cells, Cultured</topic><topic>Cholinergic system</topic><topic>Chromaffin cell</topic><topic>Chromaffin System - cytology</topic><topic>Chromaffin System - drug effects</topic><topic>Chromaffin System - metabolism</topic><topic>Cyanophyta</topic><topic>Epinephrine - metabolism</topic><topic>Marine Toxins - antagonists &amp; inhibitors</topic><topic>Marine Toxins - pharmacology</topic><topic>Mecamylamine</topic><topic>Mecamylamine - pharmacology</topic><topic>Medical sciences</topic><topic>Microcystins</topic><topic>Neuropharmacology</topic><topic>Neurotoxins - antagonists &amp; inhibitors</topic><topic>Neurotoxins - pharmacology</topic><topic>Neurotransmitters. Neurotransmission. Receptors</topic><topic>Nicotine - pharmacology</topic><topic>Nicotinic acetylcholine receptor, neuronal type</topic><topic>Nicotinic Agonists - pharmacology</topic><topic>Nicotinic receptor agonist</topic><topic>Noradrenaline release</topic><topic>Norepinephrine - metabolism</topic><topic>Pharmacology. Drug treatments</topic><topic>Potassium - pharmacology</topic><topic>Tropanes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Molloy, Leah</creatorcontrib><creatorcontrib>Wonnacott, Susan</creatorcontrib><creatorcontrib>Gallagher, Timothy</creatorcontrib><creatorcontrib>Brough, Paul A.</creatorcontrib><creatorcontrib>Livett, Bruce G.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Engineering Research Database</collection><collection>ASFA: Marine Biotechnology Abstracts</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) Marine Biotechnology Abstracts</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) Professional</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Molloy, Leah</au><au>Wonnacott, Susan</au><au>Gallagher, Timothy</au><au>Brough, Paul A.</au><au>Livett, Bruce G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anatoxin-a is a potent agonist of the nicotinic acetylcholine receptor of bovine adrenal chromaffin cells</atitle><jtitle>European journal of pharmacology</jtitle><addtitle>Eur J Pharmacol</addtitle><date>1995-05-26</date><risdate>1995</risdate><volume>289</volume><issue>3</issue><spage>447</spage><epage>453</epage><pages>447-453</pages><issn>0922-4106</issn><issn>0014-2999</issn><abstract>(+)-Anatoxin-a is a neurotoxic alkaloid produced by the cyanobacterium Anabaena flos-aquae. In this study synthetic (±)-anatoxin-a was tested on isolated bovine adrenal chromaffin cells to determine its ability to evoke secretion of endogenous catecholamines through neuronal-type nicotinic receptor activation. Anatoxin-a was found to act as a potent agonist of the secretory response of chromaffin cells with an EC 50 of 1–2 μM, compared with an EC 50 of 4–5 μM for nicotine. The cells responded to anatoxin-a and nicotine with bell-shaped concentration-response curves consistent with desensitisation at concentrations of anatoxin-a greater than 5 μM and of nicotine greater than 20 μM. The secretion of catecholamines stimulated by anatoxin-a was completely inhibited in a non-competitive manner by the nicotinic antagonist mecamylamine with an IC 50 of 0.4–0.5 μM. In the presence of depolarising concentrations of K + (15 or 50 mM), anatoxin-a increased the secretion of catecholamines in a concentration-dependent manner up to the same maximum as that achieved by anatoxin-a alone. It is concluded that anatoxin-a acts as a potent and selective nicotinic agonist, capable of evoking secretion of endogenous catecholamines from chromaffin cells via their neuronal-type nicotinic receptor.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>7556413</pmid><doi>10.1016/0922-4106(95)90153-1</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0922-4106
ispartof European journal of pharmacology, 1995-05, Vol.289 (3), p.447-453
issn 0922-4106
0014-2999
language eng
recordid cdi_proquest_miscellaneous_15597816
source ScienceDirect Freedom Collection
subjects Adrenaline release
Anabaena flos-aquae
Anatoxin-a
Animals
Bacterial Toxins - antagonists & inhibitors
Bacterial Toxins - pharmacology
Biological and medical sciences
Cattle
Cells, Cultured
Cholinergic system
Chromaffin cell
Chromaffin System - cytology
Chromaffin System - drug effects
Chromaffin System - metabolism
Cyanophyta
Epinephrine - metabolism
Marine Toxins - antagonists & inhibitors
Marine Toxins - pharmacology
Mecamylamine
Mecamylamine - pharmacology
Medical sciences
Microcystins
Neuropharmacology
Neurotoxins - antagonists & inhibitors
Neurotoxins - pharmacology
Neurotransmitters. Neurotransmission. Receptors
Nicotine - pharmacology
Nicotinic acetylcholine receptor, neuronal type
Nicotinic Agonists - pharmacology
Nicotinic receptor agonist
Noradrenaline release
Norepinephrine - metabolism
Pharmacology. Drug treatments
Potassium - pharmacology
Tropanes
title Anatoxin-a is a potent agonist of the nicotinic acetylcholine receptor of bovine adrenal chromaffin cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T13%3A31%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anatoxin-a%20is%20a%20potent%20agonist%20of%20the%20nicotinic%20acetylcholine%20receptor%20of%20bovine%20adrenal%20chromaffin%20cells&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Molloy,%20Leah&rft.date=1995-05-26&rft.volume=289&rft.issue=3&rft.spage=447&rft.epage=453&rft.pages=447-453&rft.issn=0922-4106&rft_id=info:doi/10.1016/0922-4106(95)90153-1&rft_dat=%3Cproquest_cross%3E15597816%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c417t-d6e38498e88ddf2f771e99fc4f2590e0000f34419e216db23383ba694459d6823%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=15597816&rft_id=info:pmid/7556413&rfr_iscdi=true